Kontafarma China

Kontafarma China's reported carbon emissions

Kontafarma China, headquartered in Hong Kong and operating within the real estate services sector (70), reported its carbon emissions for the period between 2019 and 2024. In 2024, the company recorded approximately 710,000 kg CO2e for Scope 2 emissions, specifically from purchased electricity. Total Scope 1 and 2 emissions for 2024 were approximately 1,470,000 kg CO2e. Looking at previous years, Scope 2 emissions from purchased electricity in 2023 amounted to approximately 727,000 kg CO2e, with total Scope 1 and 2 emissions at about 1,057,000 kg CO2e. In 2022, Kontafarma China disclosed Scope 3 emissions totalling approximately 804,000 kg CO2e, alongside Scope 1 and 2 emissions of about 2,110,000 kg CO2e. For 2020, Scope 1 emissions were approximately 1,375,000 kg CO2e and Scope 2 emissions were approximately 3,913,000 kg CO2e, with purchased electricity contributing 24,592,000 kg CO2e to Scope 2. In 2019, Scope 1 emissions were around 1,487,000 kg CO2e and Scope 2 emissions were approximately 3,922,000 kg CO2e, with purchased electricity accounting for 25,655,000 kg CO2e within Scope 2. Kontafarma China has outlined commitments to the low-carbon transition, aiming for sustainable development through continuous reduction of emissions and resource consumption. The company has set near-term reduction targets for Scope 1 and Scope 2 emissions, with a target year of 2024, stemming from its 2023 baseline. These initiatives align with a broader commitment to achieving net zero. The emissions data for Kontafarma China is cascaded from its corporate parent, Kontafarma China Holdings Limited, at cascade level 3, reflecting its status as a current subsidiary. Performance data is also inherited from Kontafarma China Holdings Limited.